Corcept Therapeutics (CORT) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $80.15 +0.30%
EPS Growth %: -96.6%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -96.6%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of ($0.02), $0.04 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $9.01 million versus the consensus estimate of $9.1 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Evercore ISI Starts Credo Tech (CRDO) at Outperform
- Tutor Perini launches $400M senior notes offering due 2033
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
